← Back to Search

Local Anesthesia for Hip Fracture Surgery

N/A
Waitlist Available
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 hours
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to compare two commonly used anesthesia techniques for hip fracture surgery in adults. The study will look at how each technique affects the patients' pain levels and the amount of pain medication needed after surgery

Who is the study for?
This trial is for adults over 18 who are having hip fracture surgery at the University of Alberta Hospital and can receive multimodal analgesia with a nerve block. It's not suitable for those who have conditions that make nerve blocks unsafe or those who don't consent to this type of anesthesia.
What is being tested?
The study compares two local/regional anesthesia techniques in hip fracture surgeries: femoral nerve block (FNB) and suprainguinal fascia iliaca block (SiFi). Patients will be randomly assigned to one technique, focusing on pain levels and postoperative painkillers needed.
What are the potential side effects?
While specific side effects aren't detailed here, typical risks associated with regional anesthesia may include discomfort at the injection site, potential nerve damage, bleeding, infection, or inadequate pain relief.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Postoperative analgesics administered
Postoperative pain
Secondary study objectives
Complications
Mobilization
Time to readiness for discharge

Side effects data

From 2019 Phase 4 trial • 1561 Patients • NCT03472469
5%
Death
100%
80%
60%
40%
20%
0%
Study treatment Arm
MAST MMPR - Escalating Dose Arm
Original MMPR - Descending Dose Arm

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SIFI local anesthesiaExperimental Treatment1 Intervention
Subjects randomized to the SiFi arm will have an ultrasound-guided suprainguinal fascia iliaca single shot block performed preoperatively in the anesthesia block room with 40ml of 0.2% ropivacaine local anesthetic. This will be reduced to 30 ml in patients under 60 kg.
Group II: FNB local anesthesiaActive Control1 Intervention
Subjects randomized to the FNB arm will have an ultrasound-guided femoral nerve single shot block performed preoperatively in the anesthesia block room with 20ml of 0.5% ropivacaine local anesthetic. This will be reduced to 15ml in patients under 60 kg.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Regional anesthesia
2020
Completed Phase 4
~2440

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
939 Previous Clinical Trials
433,807 Total Patients Enrolled
7 Trials studying Surgery
3,361 Patients Enrolled for Surgery
~71 spots leftby Mar 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top